LifeScience Clinical & Diagnostic
Sanofi Acquires Greater China Rights for Aficamten from CORXEL, Expanding HCM Treatment Reach
Cytokinetics, Incorporated announced that Sanofi will acquire exclusive rights to develop and commercialize aficamten from Corxel Pharmaceuticals (CORXEL...
December 20, 2024 | News
Hong Kong DoH Approves AGAMREE® for Duchenne Muscular Dystrophy Treatment
Department of Health (DoH) of Hong Kong approved AGAMREE® for the treatment of Duchenne muscular dystrophy (DMD) in patients aged 4 years and older...
December 20, 2024 | News
Certa Therapeutics Strengthens Asia-Pacific Leadership with Acquisition of Melbourne-Based OccuRx to Advance GPR68-Driven Fibrotic Disease Therapies
Certa Therapeutics (Certa), a biotechnology company developing innovative precision therapies for patients with fibrotic diseases, today announces the acqu...
December 19, 2024 | News
Australia’s Cartherics Secures $300K G-Rex Grant to Advance Manufacturing of Allo CAR-iNK Cells for Ovarian Cancer Trials
- Cartherics has received a US$300K G-Rex grant to support its ‘in house’ manufacturing program- Funding will enable Cartherics to generate cru...
December 18, 2024 | News
Thermo Fisher Launches MagMAX™ Sequential DNA/RNA Kit to Simplify Genomic Analysis for Blood Cancer Research
Thermo Fisher Scientific has introduced the Applied Biosystems™ MagMAX™ Sequential DNA/RNA kit to enable clinical and translational researchers...
December 18, 2024 | News
Nona Biosciences and Candid Therapeutics Collaborate to Advance Next-Generation T-Cell Engagers for Autoimmune Diseases
Nona Biosciences, a global biotechnology company providing a total solution from "Idea to IND" (I to ITM), announced a research collaboration and lic...
December 17, 2024 | News
Everest Medicines Announces First Prescription of VELSIPITY® for Ulcerative Colitis in Macau, Marking a Key Milestone in Asia
Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing an...
December 13, 2024 | News
GNT Pharma Announces Promising Nelonemdaz Results, Initiates Global Phase 3 Stroke Trials
** IND submitted to the FDA showing significantly improved patient condition when administered within 70 minutes of arrival at the Emergency Room ** *Mult...
December 12, 2024 | News
GHIT Fund and WHO Strengthen Partnership to Combat Neglected Tropical Diseases
The Global Health Innovative Technology (GHIT) Fund and the World Health Organization (WHO) have signed a memorandum of understanding (MoU) to furthe...
December 11, 2024 | News
Terumo and Medis Partner to Advance Cardiovascular Care
Collaboration combines Terumo's ePRISM™ precision medicine software platform with Medis' QFR® technology – Terumo Health Ou...
December 11, 2024 | News
Actinogen Expands Alzheimer’s Trial Across Australia and US, Eyes Interim Results in 2025
Late-stage trial in Alzheimer's opens 10 sites in US, with results due in 2025 and 2026 Appoints US-based Chief Commercial Officer, Andrew Udell X...
December 10, 2024 | News
myTomorrows Expands to APAC with New India Hub to Transform Access to Pre-Approval Treatments
Drawing on its extensive experience connecting physicians and patients to different treatment options, myTomorrows will address challenges in accessing tre...
December 09, 2024 | News
Hansa Biopharma Completes Phase 3 Trial Enrollment Ahead of Schedule for Rare Autoimmune Disease
Hansa Biopharma, "Hansa" announced it has completed the enrolment of patients in the GOOD-IDES-02 trial, a global pivotal Phase 3 trial in anti-glomerular ...
December 06, 2024 | News
NTC Announces Positive Phase II Results for NTC014 in Bacterial Conjunctivitis Treatment
NTC, an international R&D focused pharmaceutical company headquartered in Italy, presents positive results from Phase II MIRAKLE study, a mul...
December 06, 2024 | News
Most Read
- 25 Biopharma Leaders Shaping a Sustainable 2025: Innovation Meets Environmental Responsibility
- 25 Leading AI Companies to Watch in 2025: Transforming Drug Discovery and Precision Medicine
- Mr. Brendan O’Callaghan Discusses Sanofi’s Singapore Modulus Facility: Advancing Biopharma Manufacturing and Pandemic Preparedness
- Shaping the Future of PCV Care: Insights from Roche’s Stefan Scheidl on the SALWEEN Trial
- Pam Cheng Outlines AstraZeneca’s Bold Vision for Singapore’s First End-to-End ADC Manufacturing Facility
- Shaping a Health Innovation Hub: Alessandro Falcone Reflects on JLABS Singapore’s Milestone Year and Future Goals
Bio Jobs
- Avance Clinical Appoints Jessica Han as Director of Asian Operations, Strengthening Commitment to the Asian Market
- Bristol Myers Squibb Employees Cycle Coast-to-Coast to Raise $1 Million for Cancer Research
- Pfizer Australia Commits $150M to Upgrade Melbourne Facility, Bolstering Global Fight Against Antimicrobial Resistance
- SMi Systems Appoints Dr. Stefan Hamill as Vice President of Strategy to Drive Commercialisation and Growth
- Thermo Fisher Scientific Appoints William Hung as Senior Director and General Manager for Taiwan
- Cytiva Appoints Industry Veteran Pierre-Alain Ruffieux as Chief Operating Officer
News
